Ozempic: Uses, Cost, Doses, Side Effects and Warnings

Ozempic is a prescription medicine for adults with type 2 diabetes. Its active ingredient is semaglutide, a GLP-1 receptor agonist made by the Danish company Novo Nordisk, and it is injected under the skin once a week with a pen. The FDA has approved it for three uses: lowering blood sugar alongside diet and exercise, reducing the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes and established heart disease, and reducing the risk of kidney disease getting worse in adults with type 2 diabetes and chronic kidney disease. It is not approved for weight loss. Doctors can prescribe it off-label for that purpose, but the semaglutide brand approved for weight management is Wegovy.

Without insurance, Ozempic costs $199 a month for the first two fills for new patients through December 31, 2026, then $349 a month for the 0.25, 0.5 or 1 mg pen and $499 for the 2 mg pen through Novo Nordisk's own pharmacy, as of October 14, 2026. The list price is $1,027.51 per pen. A daily Ozempic tablet for type 2 diabetes reached U.S. pharmacies on May 4, 2026.

This guide is the starting point for everything we cover about Ozempic: how it works, who it is for, what it costs, how to take it, the side effects and warnings, what real users report, and what the research says. Each topic has its own detailed page, linked below.

Ozempic at a glance

Question	Answer as of October 14, 2026
Active ingredient	Semaglutide, a GLP-1 receptor agonist
Maker	Novo Nordisk
Form	Prefilled pen, injected under the skin once a week; daily tablets (1.5, 4 and 9 mg) since 2026
Injection doses	0.25 mg (starting dose), 0.5 mg, 1 mg, 2 mg
FDA-approved for	Adults with type 2 diabetes: blood sugar control, cardiovascular risk reduction, kidney protection
Approved for weight loss?	No. Weight-loss use is off-label; Wegovy is the semaglutide brand for weight management
First U.S. approval	2017
Prescription needed?	Yes, always
List price	$1,027.51 per pen (about a month)
Self-pay price (NovoCare Pharmacy)	$199 for the first two fills (new patients, through Dec. 31, 2026), then $349; $499 for 2 mg
With commercial insurance that covers it	As little as $25 a month with the savings offer
Generic available?	No approved generic semaglutide in the United States
Boxed warning	Risk of thyroid C-cell tumors (seen in rodents)

Prices are from Novo Nordisk's NovoCare pages, checked October 14, 2026. They have changed several times in the past year, so confirm before you fill a prescription.

What Ozempic is

Ozempic belongs to a class of medicines that copy a gut hormone called glucagon-like peptide-1, or GLP-1. Your intestine releases GLP-1 after you eat. It tells the pancreas to release insulin when blood sugar is rising, holds back glucagon (a hormone that pushes blood sugar up), slows the rate at which the stomach empties and acts on appetite centers in the brain.

Natural GLP-1 is broken down within minutes. Semaglutide was engineered to last: it binds to albumin in the blood and resists the enzyme that normally destroys GLP-1, which gives it a half-life of about one week. That is why a single weekly injection is enough. Because the insulin effect depends on blood sugar being high, Ozempic on its own rarely causes low blood sugar. The risk goes up when it is combined with insulin or with sulfonylureas such as glipizide or glimepiride.

People often call Ozempic "the weight-loss shot." That is understandable, because appetite drops and many people lose weight on it, but it is not what the FDA approved it for. Weight loss is an effect, not an indication. How that distinction plays out with insurance, dosing and price is covered in Ozempic for weight loss, and the head-to-head with the weight-management brand is in Ozempic vs Wegovy.

Who Ozempic is for, and who should not take it

Ozempic is prescribed for adults with type 2 diabetes, usually when metformin and lifestyle changes are not enough, or earlier when a patient has heart or kidney disease and the doctor wants a medicine with proven benefit there. It can be used alone or with other diabetes medicines, including metformin, SGLT2 inhibitors and basal insulin. It is not a substitute for insulin.

According to the FDA label, Ozempic should not be used by people who have:

• a personal or family history of medullary thyroid carcinoma (MTC);
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2);
• had a serious allergic reaction to semaglutide or any ingredient in the product.

It is not for type 1 diabetes. It is not recommended for people with severe gastroparesis. The label advises women to stop it at least two months before a planned pregnancy because semaglutide takes a long time to clear the body. Tell your prescriber if you have had pancreatitis, gallbladder disease, diabetic eye disease (retinopathy) or kidney problems, and before any surgery or procedure that involves anesthesia or deep sedation.

The boxed warning

Ozempic carries the FDA's most serious type of warning, a boxed warning, about thyroid C-cell tumors. In mice and rats, semaglutide caused these tumors at exposures similar to those in people. Whether it does the same in humans is unknown. The warning is the reason for the MTC and MEN 2 contraindications above. The label tells patients to report a lump or swelling in the neck, trouble swallowing, shortness of breath or persistent hoarseness. Routine blood tests or ultrasounds to screen for thyroid cancer are described in the label as of uncertain value.

What Ozempic costs

Your situation	What you typically pay per month
No insurance, new patient (first two fills, 0.25 or 0.5 mg)	$199 through NovoCare Pharmacy, offer through Dec. 31, 2026
No insurance, 0.25, 0.5 or 1 mg	$349
No insurance, 2 mg	$499
Ozempic tablets, no insurance	Announced at $149 (1.5 mg), $199 (4 mg), $299 (9 mg)
Commercial insurance that covers Ozempic	Your copay, reduced to as little as $25 with the savings offer (savings capped at $100 a month)
Medicare Part D	Generally covered for type 2 diabetes; your plan's copay or coinsurance applies. Manufacturer savings cards cannot be used
Medicaid	Generally covered for type 2 diabetes, often with prior authorization
Uninsured with low income	Possibly free through Novo Nordisk's Patient Assistance Program (household income at or below 200% of the federal poverty level)

Two dates matter for budgeting. The $199 introductory offer is dated to end on December 31, 2026, and Medicare's negotiated price for semaglutide products, reported at $274 for a 30-day supply, takes effect on January 1, 2027. That figure is what Medicare plans pay, not your copay. Ozempic is not part of the temporary $50 Medicare GLP-1 Bridge, which covers weight-management drugs such as Wegovy. The full breakdown, including insurance denials and how to appeal, is in Ozempic cost; the cash prices of every GLP-1 side by side are in GLP-1 cost without insurance.

Doses in brief

Weeks	Weekly dose	Notes
1 to 4	0.25 mg	Starting dose to reduce stomach side effects; not meant to control blood sugar
5 onward	0.5 mg	First maintenance dose
After at least 4 weeks on 0.5 mg, if needed	1 mg	Also the labeled dose for kidney protection
After at least 4 weeks on 1 mg, if needed	2 mg	Maximum dose

Inject once a week on the same day, at any time, with or without food, into the abdomen, thigh or upper arm. If you miss a dose, take it within five days; after that, skip it. You can move your injection day as long as the two doses are at least two days (more than 48 hours) apart. Before first use, keep pens in the refrigerator; once in use, a pen can stay at room temperature (59°F to 86°F) or in the fridge for up to 56 days. Step-by-step injection instructions, pen types and storage are in Ozempic dosage.

Side effects in brief

Stomach and bowel effects are the rule rather than the exception, especially in the first weeks and after each dose increase. In the placebo-controlled trials in the FDA label, nausea affected 15.8% of people on 0.5 mg and 20.3% on 1 mg (6.1% on placebo). Vomiting, diarrhea, abdominal pain and constipation were also more common than with placebo. Most cases were mild to moderate and eased over time, but 3.1% to 3.8% of people stopped treatment because of them.

Less common but serious risks listed in the label include pancreatitis, gallbladder disease, kidney injury from dehydration, severe stomach problems, low blood sugar when combined with insulin or a sulfonylurea, worsening of diabetic retinopathy, serious allergic reactions and aspiration of stomach contents during anesthesia. Postmarketing reports include intestinal blockage, severe constipation and hair loss. The full list, with what to watch for, is in Ozempic side effects.

Ozempic and weight loss

Ozempic became famous for weight loss before most people knew it was a diabetes drug. In its own trials, in people with type 2 diabetes, the weight change was real but modest: about 4 to 5 kg (9 to 10 lb) over 30 weeks at 0.5 to 1 mg, and 6.9 kg (about 15 lb) over 40 weeks at 2 mg. The larger numbers people quote, around 15% of body weight, come from Wegovy trials at 2.4 mg in people without diabetes.

Off-label use for weight loss is legal when a clinician prescribes it, but insurers rarely pay for Ozempic without a diabetes diagnosis, the dose stops at 2 mg, and Wegovy now costs a cash payer about the same. Weight also tends to come back when the drug is stopped. Details in Ozempic for weight loss, and every approved option compared in the best GLP-1 for weight loss.

Ozempic for type 2 diabetes

Type 2 diabetes is Ozempic's core use. In the label's 30-week monotherapy trial, A1C fell 1.4 points on 0.5 mg and 1.6 points on 1 mg from a baseline of about 8.1%, and 70% to 73% of patients reached an A1C below 7%. In the cardiovascular outcomes trial SUSTAIN-6, heart attack, stroke or cardiovascular death occurred in 6.6% of people on semaglutide versus 8.9% on placebo. In the kidney trial FLOW, semaglutide 1 mg cut the risk of major kidney outcomes by 24%. How it fits with metformin, insulin and other diabetes drugs is covered in Ozempic for diabetes; the comparison with tirzepatide is Ozempic vs Mounjaro.

"Ozempic face" and other changes in appearance

When people lose weight quickly, they lose fat from the face too: the cheeks and temples hollow, skin sags along the jaw and the face can look older. The media named it "Ozempic face," but it is not a diagnosis and it is not specific to this drug; any rapid weight loss can do it. Hair shedding, dry skin and dental problems from vomiting and dry mouth are also discussed. What dermatologists recommend, and what the evidence on fillers and other treatments shows, is in Ozempic face.

Reviews and real-world results

Experiences vary widely. Many people with diabetes see their numbers improve and lose some weight; others find the nausea hard enough to quit. In U.S. health records, about 46.5% of people with type 2 diabetes and 64.8% of those without it who started a GLP-1 drug for overweight or obesity stopped within a year, most often because of cost or insurance problems rather than because the drug did not work. Read what the trials and real-world data show, and how to judge online testimonials, in Ozempic reviews.

Ozempic pills, "Ozempic soft" and fake products

Ozempic tablets are real. They are a reformulated version of Rybelsus, the original semaglutide pill, sold in 1.5, 4 and 9 mg strengths for type 2 diabetes, taken daily on an empty stomach. They are not approved for weight loss; the semaglutide pill for weight management is the 25 mg Wegovy pill. Products sold online as "Ozempic soft," Ozempic capsules, drops, gummies or patches are not made by Novo Nordisk and contain no approved semaglutide. More in Ozempic pill and Ozempic patch.

Alcohol, food, coffee and exercise

Ozempic does not ban any food or drink, but habits change how you feel on it. Alcohol can worsen nausea and, with insulin or a sulfonylurea, raise the risk of low blood sugar. Large, fatty meals are a common trigger for stomach upset. Protein and strength training help protect muscle while you lose weight. Practical advice is in Ozempic and alcohol.

New uses under study

Semaglutide is one of the most studied drugs of the past decade. Beyond its approved uses, it has been tested in liver disease (Wegovy is approved for the liver condition MASH), alcohol use disorder, peripheral artery disease and Alzheimer's disease, where large trials reported in late 2025 found it did not slow the disease. What is proven and what is still being studied is in Ozempic new uses.

A short history

• 2017: The FDA approves Ozempic for blood sugar control in adults with type 2 diabetes.
• 2019: Rybelsus, the first semaglutide pill, is approved for type 2 diabetes.
• 2021: Wegovy, semaglutide at 2.4 mg, is approved for chronic weight management.
• 2022 to 2024: Demand driven largely by off-label weight-loss use leads to shortages; compounding pharmacies sell copies under shortage rules.
• December 2023: Falsified Ozempic is detected in the regular U.S. supply chain, one of three countries named in a World Health Organization alert the following June.
• 2025: The kidney indication is added. The FDA declares the semaglutide shortage over on February 21, 2025.
• 2026: The FDA moves against mass-marketed compounded GLP-1 products (February and April). Ozempic tablets reach pharmacies on May 4.

Starting Ozempic: step by step

1. See your clinician. A primary care doctor, endocrinologist, nurse practitioner or physician assistant reviews your A1C, weight, blood pressure, kidney function, eye health, current medicines and history of pancreatitis, gallbladder disease or thyroid cancer. Telehealth visits are an option; see how to get Ozempic.
2. Check coverage. Look up Ozempic on your plan's formulary. Most commercial plans require prior authorization confirming type 2 diabetes. If you have commercial coverage, activate the savings offer; if you pay cash, compare NovoCare Pharmacy's price with your pharmacy's.
3. Learn the pen. Ask the pharmacist or your clinic to walk you through attaching a needle, the first-use flow check and holding the button for six seconds.
4. The first four weeks. Take 0.25 mg weekly. Eat smaller meals, stop when you feel full, drink fluids and keep high-fat foods modest.
5. Follow-up. After about three months your clinician rechecks A1C and decides whether to stay at your dose, increase it or change treatment.

Buying Ozempic safely

Ozempic is sold only with a prescription, through a state-licensed pharmacy. The FDA has warned that counterfeit Ozempic has been found in the United States, and the World Health Organization's June 2024 alert listed three falsified batches found in Brazil, the United Kingdom and the U.S. between October and December 2023. A fake pen may hold the wrong dose, the wrong drug or contaminants. Red flags include prices far below the manufacturer's, no prescription or medical screening, packaging that looks different from what you received before, and spelling errors on the label. The FDA's BeSafeRx tool helps you check an online pharmacy. Report suspected counterfeits and side effects to the FDA through MedWatch.

Compounded semaglutide is a separate issue. It is not FDA-approved, and since the shortage ended, the FDA has been narrowing the rules that allowed near-copies to be sold. There is no approved generic.

When to get medical help right away

Most stomach side effects fade, but some symptoms need prompt care. Call your prescriber or seek urgent care if you have:

• severe abdominal pain that will not go away, with or without vomiting, sometimes spreading to the back (possible pancreatitis);
• pain in the upper right abdomen, fever, or yellowing of the skin or eyes (possible gallbladder problems);
• vomiting or diarrhea that keeps you from holding down fluids, with thirst, dizziness or little urine (dehydration can injure the kidneys);
• sudden changes in vision;
• symptoms of low blood sugar such as shakiness, sweating, confusion or a fast heartbeat, especially if you also take insulin or a sulfonylurea;
• a lump in the neck, trouble swallowing or persistent hoarseness.

Call 911 for swelling of the face, lips, tongue or throat, trouble breathing, or fainting. These can signal a severe allergic reaction.

Key points

• Ozempic is semaglutide, a once-weekly injection approved for adults with type 2 diabetes, with added heart and kidney indications.
• Doses climb from 0.25 mg to 0.5 mg, then 1 mg or 2 mg if needed.
• Self-pay prices are $199 to $499 a month; insurance and Medicare generally cover it for diabetes.
• Nausea and other stomach effects are common; pancreatitis and gallbladder disease are rare but serious.
• Weight-loss use is off-label. "Ozempic soft," patches and similar products are not the real drug.
• Buy only from a licensed pharmacy with a prescription, and talk to your prescriber before starting, changing or stopping treatment.

This guide is general information, not medical advice. The FDA label, your prescriber and your pharmacist are the final word on your treatment.